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Abstract
Background: Functional and molecular integrity of cardiomyocytes (CMs) derived from induced pluripotent stem
(iPS) cells is essential for their use in tissue repair, disease modelling and drug screening. In this study we
compared global transcriptomes of beating clusters (BCs) microdissected from differentiating human iPS cells and
embryonic stem (ES) cells.
Results: Hierarchical clustering and principal component analysis revealed that iPS-BCs and ES-BCs cluster together,
are similarly enriched for cardiospecific genes and differ in expression of only 1.9% of present transcripts. Similarly,
sarcomeric organization, electrophysiological properties and calcium handling of iPS-CMs were indistinguishable
from those of ES-CMs. Gene ontology analysis revealed that among 204 genes that were upregulated in iPS-BCs vs
ES-BCs the processes related to extracellular matrix, cell adhesion and tissue development were overrepresented.
Interestingly, 47 of 106 genes that were upregulated in undifferentiated iPS vs ES cells remained enriched in iPS-
BCs vs ES-BCs. Most of these genes were found to be highly expressed in fibroblasts used for reprogramming and
34% overlapped with the recently reported iPS cell-enriched genes.
Conclusions: These data suggest that iPS-BCs are transcriptionally highly similar to ES-BCs. However, iPS-BCs
appear to share some somatic cell signature with undifferentiated iPS cells. Thus, iPS-BCs may not be perfectly
identical to ES-BCs. These minor differences in the expression profiles may occur due to differential cellular
composition of iPS-BCs and ES-BCs, due to retention of some genetic profile of somatic cells in differentiated iPS
cell-derivatives, or both.
Background
Reprogramming of adult somatic cells to induced pluri-
potent stem (iPS) cells by overexpression of a defined
set of transcription factors represents a significant
breakthrough in stem cell research [1-6]. One important
prerequisite for scientific and therapeutic application of
iPS cells is that they can efficiently differentiate into spe-
cific functionally and molecularly intact cell lineages.
Initial studies have demonstrated that diverse types of
mature cell derivatives of all three embryonic germ
layers can be differentiated from iPS cells [7-12].
Among these differentiated cells, cardiomyocytes (CMs)
represent the most intensively studied cell type [13-15].
Detailed electrophysiological analyses of murine
[7,16-19] and human [20-26] iPS cell-derived CMs (iPS-
CMs) demonstrated that they are functionally intact and
have similar properties to CMs derived from conven-
tional ES cells (ES-CMs).
Although comparisons between iPS cells and conven-
tional ES cells revealed that they have highly similar
growth characteristics, gene expression profiles, epige-
netic status and developmental potential [3,5,6,27,28],
recent comprehensive analyses of various undifferen-
tiated ES and iPS cell lines showed that iPS cells may
not be perfectly identical to conventional ES cells at the
molecular level [29-31]. These studies demonstrated
that iPS cells are characterized by a unique gene and
miRNA expression signature as well as a CpG
* Correspondence: j.hescheler@uni-koeln.de; tomo.saric@uni-koeln.de
1Center for Physiology and Pathophysiology, Institute for Neurophysiology,
University of Cologne, Robert-Koch-Str. 39, 50931 Cologne, Germany
Full list of author information is available at the end of the article
Gupta et al. BMC Developmental Biology 2010, 10:98
http://www.biomedcentral.com/1471-213X/10/98
© 2010 Gupta et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.methylation pattern, which distinguish them from ES
cells. However, the comparison of global transcriptomes
of mature cells differentiated from ES and iPS cells has
not yet been performed, and it is not clear whether
molecular differences between iPS and ES cells are
retained upon their differentiation into mature cells.
Full transcriptional profiles of human ES-CMs have
been reported by several groups. Synnergren and cowor-
kers differentiated the human ES cell line SA002 to car-
diac lineage in an embryoid body (EB) system and CMs
were enriched by mechanical dissection of sponta-
neously beating clusters (BCs) [32]. The results of this
study indicated that human ES-BCs, despite being com-
posed of different cell types, are highly enriched for
CM-specific transcripts and display high similarities to
human fetal heart tissue. Cao and coworkers reported
the transcriptional profile of Percoll density gradient-
enriched human H9 ES-CMs that were isolated by cen-
trifugation to a purity of about 45% [33], and most
recently, microarray analyses were carried out with
highly purified CMs (> 99%) that were generated by
drug selection from the transgenic human ES cell line
HES3 [34] and H9 [35]. These studies provide the first
comprehensive characterization of the molecular signa-
ture of purified human ES-CMs revealing high similari-
ties between expression profiles of ES-CMs and human
native CMs.
The purpose of this study was to determine the degree
of molecular similarity between CMs and other differen-
tiated cell types present in microdissected BCs derived
from human iPS cells and conventional ES cells. Our
data indicates that iPS-BCs are transcriptionally highly
similar to ES-BCs. However, iPS-BCs appear to share
some somatic cell signature with undifferentiated iPS
cells and express higher levels of transcripts encoding
for some extracellular matrix components and cell adhe-
sion molecules than ES-BCs. This expression profile
may reflect either the differential cellular composition or
activity in iPS- and ES-BCs, partial retention of genetic
signature of somatic cells in differentiated iPS cell-deri-
vatives, or both. These findings emphasize the necessity
for a careful assessment of the differentiation capacity of
iPS cells of various somatic cell origins and molecular
profiles of specific mature iPS and ES cell-derivatives, so
as to determine whether any alterations may exist that
could affect their use for regenerative medicine and
research.
Results
Cardiac differentiation of human iPS and ES cells
The human iPS cell line derived from foreskin fibro-
blasts, clone 1 (C1), [6] and the human ES cell line
HES-2 were differentiated to CMs using the END2 co-
culture system [15] (Additional file 1, Figure S1). Upon
inducing differentiation, spontaneously contracting clus-
ters were first observed at day 11 in cultures of both
cell lines. At day 15 of differentiation, the fraction of
clusters that exhibited spontaneous contractions in iPS
and ES cell cultures was 12.8 ± 3.5% and 16.0 ± 4.8%,
respectively (n = 9, p = 0.128), (Additional file 1, Figure
S2A). With further cultivation no additional beating
areas appeared. In BCs derived from iPS and ES cells
the CMs represented, respectively, 16.7 ± 5.1% and 15.0
± 2.6% of all cells (Additional file 1, Figure S2B).
The contraction rates of these BCs were similar in iPS
and ES cell cultures (46 ± 6.8 beats/min for iPS cells
and 43 ± 4.5 beats/min for ES cells), (Additional file 1,
Figure S2C). These data indicate that the iPS cell line
Foreskin C1 differentiates to CMs at rates comparable
to the ES cell line HES-2 and possesses similar beating
characteristics.
Expression of cardiospecific genes and sarcomeric
proteins in BCs
To confirm the presence of CMs in BCs isolated from
differentiating iPS and ES cells we examined the expres-
sion of cardiospecific markers using qRT-PCR (primer
sequences are given in Additional file 1, Table S1) and
immunocytochemistry. The data on expression of the
endogenous and viral pluripotency marker OCT4 in
undifferentiated and differentiated iPS and ES cells is
discussed in Additional file 1 (Figure S3 and Supple-
mentary results). The expression of mRNAs for tran-
scription factors NKX2.5 and GATA4, and the cardiac
structural proteins myosin light chain 2 ventricular iso-
form (MLC2v), a-actinin (ACTN2)a n da-myosin heavy
chain (MYH6) was undetectable or very low in undiffer-
entiated cells (Figure 1A). However, their expression
was strongly upregulated in BCs at day 18 of differentia-
tion (Figure 1A). The specific marker of skeletal muscle,
myosin heavy chain 2 (MYH2), was not detectable in
these aggregates (Figure 1A). Similar levels of the car-
diac genes in microdissected BCs of both cell types indi-
cate that they contain comparable amounts of CMs,
which is in agreement with the CM-counting data in
the Additional file 1, Figure S2B. Immunocytochemical
analyses revealed that CMs in day 18 iPS- and ES-BCs
stain positively for cardiac proteins a-actinin and tropo-
nin T (cTnT) and display typical pattern of cross-stria-
tions indicative of sarcomeric organization in CMs
(Figure 1B). The highly ordered striated pattern is high-
lighted in high resolution images and clearly recapitu-
lates the normal architecture of the contractile
apparatus in functional CMs.
Intact adrenergic and muscarinergic signaling in iPS-CMs
MEA measurements were performed to verify the func-
tional integrity of CMs in microdissected BCs. In the
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Page 2 of 19Figure 1 Expression of cardiac transcripts and proteins in cardiomyocytes derived from human iPS and ES cells. A. qRT-PCR assessment
of expression of cardiac specific genes NKX2.5, MLC2v, ACTN2, MYH6, GATA4 and a skeletal muscle gene MYH2 in undifferentiated iPS and ES cells
and their corresponding beating clusters (BC) microdissected at day 18 of differentiation. The data are means of triplicate analyses ± SEM.
B. Anti-sarcomeric cardiac actinin and cardiac troponin T stainings in HES2- (upper panels) and iPS(Forskin) C1-derived (lower panels)
cardiomyocytes. Spontaneously beating outgrowths were microdissected at day 15 of differentiation and replated on fibronectin-coated plates.
Adherent beating clusters were used for staining 3-5 days later. Scale bar: 20 μm.
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Page 3 of 19absence of pharmacological stimulation, iPS-CMs and
ES-CMs exhibited similar spontaneous electrical activity
with the field potential (FP) frequencies of 1.04 ± 0.39
Hz (n = 11) and 1.15 ± 0.66 Hz (n = 9), respectively
(Figure 2 and Additional file 1, Table S2). Application of
b-adrenergic receptor agonist isoproterenol (ISO) signif-
icantly increased the basal FP frequency in both cell
populations to 1.75 ± 0.44 Hz (iPS cells, n = 5) and 1.96
± 0.63 Hz (ES cells, n = 4), whereas the treatment with
the muscarinic receptor agonist carbachol (CCh) led to
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Figure 2 Electrophysiological analysis by multielectrode arrays (MEAs). A. Representative field potential (FP) recordings of human iPS- and ES-
BCs in the absence or presence of the alpha-adrenergic agonist isoproterenol (ISO, 1 μmol/L) or muscarinic agonist carbachol (CCh, 10 μmol/L).
B. Statistical analysis of FP frequencies in MEA measurements. Data are shown as means of ± SEM. * p < 0.05.
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Page 4 of 19its reduction in iPS-BCs and ES-BCs to 0.23 ± 0.21 Hz
(n = 6) and 0.35 ± 0.42 Hz (n = 5), respectively (Figure
2, and Additional file 1, Table S2). These results suggest
that iPS-CMs express functional b-adrenergic and mus-
carinic receptors and their associated signaling pathways
in a manner indistinguishable from ES-CMs.
Spontaneous Ca
2+ transients in iPS-CMs
To further characterize the functional properties of iPS-
CMs, we have compared spontaneous Ca
2+ release in
BCs of human ES and iPS origin using fluorometric Ca
2+
imaging with Fura-2 AM (Figure 3A). Both cell types
showed rhythmic Ca
2+ transients with identical baseline
and amplitude, maximum upstroke- and maximum decay
velocity, time to peak, total transient time and time to
half peak relaxation (Figure 3B, 3C and Additional file 1,
Table S3). Simultaneous observation of contractions and
Ca
2+ transients revealed that each Ca
2+ transient was
accompanied by a single contraction of the examined
iPS- and ES-BCs, being indicative of an intact cardiac
excitation-contraction coupling (Additional file 1, Table
S4 and Supplementary results). In order to determine
whether functional Ca
2+ stores in the sarcoplasmic reti-
culum (SR) are expressed in iPS-CMs we investigated the
effects of caffeine on the cells. In all experiments
increased beating frequency was observed due to the
mechanical stimulation caused by the control Tyrode
perfusion with the ‘puff’-device (Figure 3B, 3D; p < 0.01).
Upon caffeine application an additional short-term
increase of the frequency of spontaneous Ca
2+-release
occurred (Figure 3B, 3D). Concomitantly, the magnitude
of the transients decreased and the basal Ca
2+ level
increased (Figure 3B, 3E; p < 0.01). Increased Ca
2+ levels
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Figure 3 Spontaneous Ca
2+ transients of HES-2 and iPS(Foreskin) C1-derived contracting cell clusters. A. Transmission light images of
two beating cell aggregates derived from ES and iPS cells that were loaded with Fura-2 AM (upper row) and the corresponding emitted
fluorescence light presented in pseudo color. (Scale bar = 100 μm). B. Response of spontaneously beating aggregates derived by both cell lines
to caffeine (10 mM) treatment indicates the existence of caffeine-releasable Ca
2+ stores in this stage of development (up to 2 weeks after onset
of beating). Two representative experiments are shown: 30 s tyrode perfusion followed by ‘puff’ perfusion of tyrode directly in front of the cells
for the same time period with subsequent caffeine application. Both cell types temporally show a caffeine evoked increase of basal, systolic and
diastolic [Ca
2+]i. However the Ca
2+ amplitude is reduced, accompanied by an increase in beating frequency. C. Representative single tracings.
The transients show statistically identical characteristics regarding basal Ca
2+ level, amplitude, maximum upstroke velocity (Vmax, upstroke) and
maximum decay velocity (Vmax, decay) with p > 0.05 (data not shown).D +E Caffeine response (n = 7 for iPS-CMs; n = 7 for ES-CMs). Beating
frequency is increased by ‘puff’-perfusion and subsequent caffeine application in both celltypes (D). Basal calcium levels and the maximum value
(Amax) are raised significantly after caffeine treatment (E). * = p < 0.05; ** = p < 0.01. Additional analyses of these measurements are provided in
Additional file 1, Tables S3 and S4.
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Page 5 of 19in a transient response to caffeine indicate the presence
of functional SR Ca
2+-stores in iPS-CMs.
Comparative global transcriptome analysis
Functional analyses presented above and those
reported by others [20-24,26] indicate that iPS-CMs
are electrophysiologically highly similar to those of
their ES cell counterparts. To establish whether this
functional similarity is mirrored at the molecular level,
we compared the global gene expression profiles of
undifferentiated ES and iPS cells and beating areas of
differentiated iPS and ES cells microdissected at day 18
of differentiation. Fetal (FH) and adult human hearts
(AH) were included to serve as positive controls for
cardiac transcripts. Samples used for transcriptional
analyses are described in Additional file 1, Table S5.
All data have been deposited in NCBI’sG e n eE x p r e s -
sion Omnibus and are accessible through GEO Series
accession number GSE17579 http://www.ncbi.nlm.nih.
gov/geo/query/acc.cgi?token=tzqzjeawkmame-
du&acc=GSE 17579. Among expressed transcripts,
4254 probe sets (25.3%) were identified as variable
across samples (Additional file 2, Table S6). Principal
component analysis (PCA) with this data set showed
that samples cluster in four groups corresponding to a)
undifferentiated ES and iPS cells, b) microdissected ES-
and iPS-BCs, c) fetal heart and d) adult heart (Figure
4A). Hierarchical clustering also showed that undiffer-
entiated iPS cells cluster together with undifferentiated
ES cells and iPS-BCs together with ES-BCs (Figure
4B). The transcriptional profiles of FH and AH were
more related to those of iPS-BCs and ES-BCs than to
those of their undifferentiated counterparts. Further-
more, scatter-plot analysis of every probe set on the
array further emphasized a close correlation of gene
expression levels between iPS and ES cells (r
2 =0 . 9 6±
0.01, n = 9) as well as between iPS-BCs and ES-BCs
(r
2 =0 . 9 3±0 . 0 4 ,n=9 )( F i g u r e4 C ) .I nc o n t r a s t ,c o r -
relation between iPS cells and iPS-BCs as well as
between undifferentiated ES cells and ES-BCs was sig-
nificantly lower (r
2 =0 . 8 7±0 . 0 2 ,n=9 ) .Ac l o s e rl o o k
at differentially expressed genes (p-value < 0.05; > 2-
fold change; difference between mean intensity signals
> 100) revealed that only 198 probe sets (1.19% of pre-
sent transcripts or 4.65% of variable genes) significantly
differ in their expression levels between ES and iPS
cells and only 330 probe sets (1.91% of present tran-
scripts and 7.76% of variable genes) were differentially
expressed between ES-BCs and iPS-BCs (Figure 4D).
Complete lists of up- and down-regulated genes in
these comparisons are provided in Additional file 3
(Tables S7 and S8) and Additional file 4 (Tables S9
and S10).
Genes commonly upregulated in iPS cells and iPS-BCs
In order to determine whether any of the 106 unique
transcripts found to be overexpressed in iPS cells in
iPS- versus ES-cell comparison also remain over-
expressed in iPS-BCs compared to ES-BCs we searched
for overlapping genes in these two lists of overexpressed
genes and found that among 106 unique iPS cell-
enriched transcripts 47 (44.3%) were also present on the
list of 204 iPS-BC-enriched transcripts (Figure 4E and
Table 1). Using Fisher’s exact test we have determined
that this overlap was highly statistically significant (p =
6,7e-28). Moreover, 38 (80.9%) of these overlapping
transcripts remained expressed at similar levels in undif-
ferentiated iPS cells and differentiated iPS-BCs (Table
1). The gene ontology (GO) analysis of iPS cell-upregu-
lated transcripts did not reveal significant enrichment
for any GO-term in this group of genes (data not
shown).
Verification of these microarray data with quantitative
PCR revealed that out of 11 genes selected from this list
10 genes (C O M T ,D Y N L T 3 ,N M E 4 ,O X C T 1 ,M G M T ,
PTGR1, MGC3207, CKLF, ZNF167, ZNF626,a n d
RPL39L) were expressed at very low levels or not at all
in ES cells and ES-BCs, but were highly upregulated in
iPS cells and iPS-BCs (Figure 5, for comparison see
microarray expression data in Table 1). Interestingly, all
of these 10 iPS/iPS-BC-enriched genes were also
strongly expressed in fibroblasts used for reprogram-
ming, their expression levels in fibroblasts being similar
to those in iPS cells and iPS-BCs (Figure 5). These data
suggest that this group of genes may belong to fibroblast
specific-genes that could not be repressed in the process
of reprogramming and still remain upregulated in iPS
cells. Indeed, two recent studies demonstrated that iPS
cells are characterized by a unique gene expression sig-
nature, which distinguishest h e mf r o mE Sc e l l s[ 2 9 , 3 1 ] .
By comparing these data with our list of 47 transcripts
upregulated in iPS cells and iPS-BCs we found that 16
of these transcripts (34%) were also detected in these
previous studies to be specifically expressed in multiple
human iPS cell lines in comparison with various ES cell
lines (Table 1). Thus, iPS cell-signature genes appear to
be specifically expressed in iPS-BCs but not ES-BCs.
Gene ontology analysis of genes upregulated in iPS-BCs
vs ES-BCs
In order to determine which biological terms are
enriched in iPS-BCs compared to ES-BCs, we have per-
formed a functional annotation clustering analysis of
204 unique transcripts that were found to be upregu-
lated in iPS-BCs (see Additional file 4, Table S7). Con-
sidering only the significant GO-terms with the p-value
< 0.001 this analysis revealed the overrepresentation in
Gupta et al. BMC Developmental Biology 2010, 10:98
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Page 6 of 19Figure 4 Global transcriptional analysis of human iPS and ES cells and their corresponding beating clusters. A. Principal component
analysis of 4254 variant genes. B. Hierarchical clustering analysis of variant genes. C. Scatter-plots comparing global gene expression profiles
between undifferentiated ES and iPS cells, iPS-BCs and ES-BCs and undifferentiated iPS cells and iPS-BCs. D. The number of differentially
expressed genes (p < 0.05, 2- fold change) in various intergroup comparisons. E. Venn diagram of iPS cell-upregulated (compared to ES cells)
and iPS-BC-upregulated (compared to ES-BCs) transcripts and the number of overlapping genes. The p-value has been calculated using the
Fisher’s exact test.
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Page 7 of 19Table 1 List of 48 genes commonly upregulated in human iPS cells and human iPS-beating clusters (BCs) as compared
to, respectively, human ES cells and human ES-BCs
Symbol
1 Mean
ES
Mean ES-
BC
p-value
2 (ES vs ES-
BC)
Mean
iPS
Mean iPS-
BC
p-value
2 (iPS vs iPS-
BC)
Fold change iPS-BC/
ES-BC
Overlap
3
ADFP 94 118 > 0,05 2125 1490 > 0,05 12,6 -
ANGEL2 510 430 > 0,05 1181 1198 > 0,05 2,8 -
B3GALNT1 81 78 > 0,05 386 443 > 0,05 5,7 -
C1orf176 95 94 > 0,05 229 231 > 0,05 2,5 -
CFLAR 120 92 > 0,05 294 215 > 0,05 2,3 Chin-E
CKLF 417 290 > 0,05 921 582 > 0,05 2,0 -
COMT 257 194 > 0,05 1172 1958 > 0,05 10,1 Chin-E;
Marchetto
CYorf15A 123 94 > 0,05 566 407 > 0,05 4,3 -
CYorf15B 78 85 > 0,05 237 189 > 0,05 2,2 -
DNAJC15 112 179 > 0,05 504 402 > 0,05 2,2 Chin-E
EIF1AY 75 77 > 0,05 1569 2114 > 0,05 27,5 -
EPSTI1 155 136 > 0,05 345 651 > 0,05 4,8 Chin-E
HLA-B 203 158 > 0,05 614 513 > 0,05 3,2 Chin-E
IRAK1 97 92 > 0,05 511 480 > 0,05 5,2 -
JARID1D 83 79 > 0,05 407 489 > 0,05 6,2 -
LEMD3 516 480 > 0,05 1382 1278 > 0,05 2,7 -
MAP1LC3A 76 91 > 0,05 753 1276 > 0,05 14,0 Chin-E
MEIS3P1 87 112 > 0,05 305 362 > 0,05 3,2 -
MGC3207 430 299 > 0,05 1040 757 > 0,05 2,5 -
MGMT 83 76 > 0,05 453 405 > 0,05 5,3 -
MNS1 89 93 > 0,05 325 217 > 0,05 2,3 -
NAPRT1 196 190 > 0,05 679 382 > 0,05 2,0 -
NLGN4Y 79 80 > 0,05 385 325 > 0,05 4,1 -
NME4 89 127 > 0,05 7001 5461 > 0,05 43,0 Chin-L;
Marchetto
OXCT1 90 94 > 0,05 272 358 > 0,05 3,8 -
PTGR1 84 79 > 0,05 1613 1290 > 0,05 16,3 Chin-E
PUS7L 92 82 > 0,05 327 211 > 0,05 2,6 -
RPS4Y1 86 96 > 0,05 4190 4645 > 0,05 48,4 -
SLC39A8 86 91 > 0,05 263 269 > 0,05 3,0 Marchetto
SPIN3 84 96 > 0,05 335 206 > 0,05 2,1 -
TFCP2 355 190 > 0,05 765 466 > 0,05 2,5 -
TMBIM4 223 232 > 0,05 1848 1545 > 0,05 6,7 Chin-L
TRIM4 87 79 > 0,05 307 340 > 0,05 4,3 -
TSPYL5 79 82 > 0,05 296 350 > 0,05 4,3 Chin-E, L
ZNF167 89 76 > 0,05 262 232 > 0,05 3,1 Marchetto
ZNF22 123 256 0,0003 1807 1311 > 0,05 5,1 -
ZNF248 95 76 > 0,05 202 212 > 0,05 2,8 Chin-E
ZNF626 79 77 > 0,05 196 239 > 0,05 3,1 -
CXCL12 399 958 > 0,05 815 1782 0,0245 1,9 -
DYNLT3 82 96 > 0,05 227 455 0 4,7 Chin-E
GGCT 92 179 > 0,05 1908 836 0,0007 4,7 -
GRTP1 85 82 > 0,05 571 201 0 2,5 -
PHF11 79 79 > 0,05 651 307 0 3,9 -
PRKAR1A 83 83 > 0,05 651 1357 0,0003 16,3 -
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Page 8 of 19iPS-BCs of functional categories related to collagen,
extracellular matrix, cell adhesion and tissue develop-
ment and morphogenesis (Table 2). Genes in these cate-
gories included various types of collagens (COL1A1,
COL3A1, COL4A1, COL5A1, COL5A2, COL6A3)a n d
other extracellular matrix components (LUM, LAMB1,
CTGF), cell surface proteins involved in cell-cell interac-
tions (CD36, CD44, CD47) and a variety of transcription
factors involved in tissue development and morphogen-
esis (HOXA5, HOXB5, SNAI2, NR2F2). These transcripts
were increased in iPS-BCs vs ES-BCs in average by 3,3 ±
2,1 -fold (Additional file 5, Table S11). Since these tran-
scripts are expressed by specific cell types (e.g. collagens
by fibroblasts) or involved in specific biological pro-
cesses (e.g. HOXB5 in lung and gut development), these
findings indicate that transcriptional differences between
iPS-BCs and ES-BCs may partially occur due to higher
abundance (or higher transcriptional activity) of specific
non-cardiac cell types in these clusters.
Microarray analysis of human ES cell- and CM-specific and
enriched genes
We have further compared the expression levels of
selected transcripts known to be specifically expressed
or enriched in undifferentiated ES cells or CMs. 93.4%
of human ES cell-specific or -enriched genes were
expressed at similar levels in iPS and ES cells (Figure 6
and Additional file 6, Tables S12 and S13). Furthermore,
89.2% of 83 cardiac specific or enriched genes were
expressed at similar levels in iPS-BCs and ES-BCs and
out of 34 BC- or CM-associated genes identified in pre-
vious studies [32-36] 28 (82.4%) were enriched to a
similar extent in both iPS-BCs and ES-BCs in our study
(Figure 6 and Additional file 6, Table S14). Further ela-
boration of these microarray data is given in the Addi-
tional file 1, Supplementary results.
Microarray data were validated by comparative qPCR
analysis of undifferentiated iPS and ES cells with
Human embryonic stem cell 96 StellARray™ qPCR Array
(Lonza). This analysis revealed that 82 genes (91.1%)
were detected with both methods as being expressed at
undistinguishable levels in ES and iPS cells (p > 0.05
and fold change < 2) (Additional file 7, Table S15).
Comparison of transcriptional profiles between
undifferentiated and differentiated iPS and ES cells
While transcriptomes of BCs derived from iPS and ES
cells were highly similar, as many as 2394 (13.73% of
present transcripts) and 2106 probe sets (12.75% of pre-
sent transcripts) were differentially expressed between
undifferentiated iPS cells and iPS-BCs and between
undifferentiated ES cells and ES-BCs, respectively (Fig-
ure 4D). Among the most upregulated genes in iPS-BCs
and ES-BCs were known cardiac genes and the most
downregulated genes in both types of BCs belonged to
pluripotency markers. More extensive discussion on this
subject is provided in the Supplementary results (Addi-
tional file 1) and the lists of differentially expressed
genes can be found in Additional file 8, Tables S16-S19.
Functional annotation analysis was performed in
DAVID to identify the most important biological pro-
cesses that are significantly enriched in iPS- and ES-BCs
compared to their undifferentiated counterparts. Taking
into account only the GO-terms that had more than 3
genes and p-value < 0,001 thisa n a l y s i sr e v e a l e dt h a ti n
categories biological process, molecular function, cellular
component and KEGG pathway the overlap between
terms enriched in iPS-BCs and ES-BCs was highly sig-
nificant as determined by Fisher’s exact test (Figure 7
and Additional file 9, Table S20). Among the most
enriched GO-terms related to cardiomyocytes were
heart development, blood vessel and muscle tissue
development, myofibril assembly, muscle contraction,
ECM structural constituent, calcium ion binding, actin
binding, contractile fiber, myofibril, sarcomere, actin
cytoskeleton, collagen, Z disc, I band and A band, focal
Table 1 List of 48 genes commonly upregulated in human iPS cells and human iPS-beating clusters (BCs) as compared
to, respectively, human ES cells and human ES-BCs (Continued)
RPL39L 977 155 0 2352 668 0 4,3 -
ZNF280D 78 78 > 0,05 511 178 0,0138 2,3 Chin E
KDELR3 79 92 > 0,05 185 488 0,0004 5,3 Chin-E
RPL39L 221 107 > 0,05 997 280 0 2,6 -
Mean ± SD 6,9 ± 9,4
1 Genes with names depicted in bold are expressed at similar levels in iPS cells and iPS cell-derived beating clusters (iPS-BCs).
2 The p-value of > 0.05 indicates that the differences in gene expression levels in comparisons iPS vs iPS-BC and ES vs ES-BC was not statistically significant. For
differentially expressed genes in these comparisons the exact p-value is indicated. All genes in this table were differentially expressed (p < 0.05, > 2-fold change)
in comparisons iPS vs ES and iPS-BC vs ES-BC.
3 Overlap with iPS cell-specific genes reported by Chin et al. [29] and/or Marchetto et al. [31] is indicated. Two genes (NME4 and COMT) in this table were
reported to be overexpressed in human iPS cells by both groups. One gene (TSPYL5) from our list was reported to be overexpressed in both early and late
passage iPS cells by Chin et al. ("Chin-E, L”). The gene TMBIM4 was found to be overexpressed only in late passage iPS cells (three different cell lines) by Chin et
al. (“Chin-L”). All other probe sets in this table were detected only in early passage iPS cells (five different cell lines) by Chin et al. (“Chin-E”).
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Page 9 of 19Figure 5 Quantitative RT-PCR validation of selected genes commonly upregulated in iPS cells and iPS-BCs. Expression levels of genes
indicated above each panel were determined by qRT-PCR in undifferentiated iPS and ES cells, iPS-BCs and ES-BCs as well as in human foreskin
fibroblasts. Data for each gene are presented as expression levels relative to undifferentiated human ES cells and are given as the mean ± SEM
of triplicate measurements. For comparison, the ratio of signal intensities between iPS-BCs and ES-BCs as found in microarray analyses is given
for each gene.
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cardiomyopathy, and ALK pathway in cardiac myocytes
(Figure 7 and Additional file 9, Table S20). However, a
number of GO-terms were differentially enriched
between iPS-BCs and ES-BCs. For example, in the cate-
gory biological process the iPS-BCs but not ES-BCs
were enriched for GO-terms such as kidney develop-
ment, mesenchyme development, angiogenesis, neural
crest cell development, central nervous system develop-
ment and others, while ES-BCs were enriched, among
others, for GO-terms sarcomere organization, muscle
thin filament assembly, heart septum morphogenesis
and skeletal myofibril assembly (Additional file 9, Table
S20). Although these differences may reflect a certain
degree of heterogeneity in cellular composition of iPS-
and ES-BCs, most categories were enriched in both iPS-
BCs and ES-BCs to the same extent, suggesting that
they are very similar.
Discussion
In this study we show that global gene expression pro-
files of functionally intact CMs and other differentiated
cell types enriched in microdissected iPS-BCs and ES-
BCs are highly similar. Cardiac specific genes identified
in previous reports using enriched [32,33,36] or highly
purified human ES-CM-preparations [34,35] were simi-
larly expressed in both iPS-BCs and ES-BCs and only a
few percent of transcripts classified as present among all
samples were differentially expressed between these two
cell populations. The small difference in transcriptomes
between iPS-BCs and ES-BCs was not significantly
greater than the difference between undifferentiated iPS
and ES cells or between different ES cell or different iPS
cell lines as reported by others [37-40].
Of interest is the observation that 44.3% of transcripts
(47 out of 106) that were upregulated in iPS cells com-
pared to ES cells also remained upregulated in iPS-BCs
compared to ES-BCs. Statistical analysis revealed that
this overlap is unlikely to occur by chance. Many of
these genes were expressed at very high levels in iPS
cells and iPS-BCs but were absent from both undifferen-
tiated ES cells and ES-BCs. We could not identify these
genes on the list of 530 genes reported to be upregu-
lated in microdissected BCs derived from human ES cell
line SA002 by Synnergren and coworkers [32]. However,
the significant fraction of these genes (16 out of 47) has
been found by other groups to be specifically expressed
in various human iPS cell lines compared to ES cell
lines [29,31]. In one another comparison, one third of
our 47 genes was also found to be overexpressed in at
least five different undifferentiated iPS cell lines when
compared to several independently derived human ES
cell lines (Natalia Polouliakh, Sony Computer Science
Laboratories, Tokyo, Japan, personal communication).
T h u s ,t h e s eg e n e sm a yb e l o n gt oau n i q u eg e n ee x p r e s -
sion signature of iPS cells [29,31]. Interestingly, many of
these 47 genes have been found to be expressed in fore-
skin fibroblasts [6] and this was also confirmed by qRT-
PCR in our study for 10 randomly selected genes. Thus,
this subset of genes may represent fibroblast-associated
genes that are expressed in iPS cells because they are
refractory to epigenetic silencing during reprogramming,
as suggested previously [29,31]. Recent meta-analysis of
multiple transcriptional data sets derived from human
fibroblasts, ES and iPS cells also revealed that iPS cells
share four-times more genes in common with fibroblasts
from which they were derived than ES cells and fibro-
blasts [40].
While the retention of epigenetic memory of somatic
cells in undifferentiated iPS cells may explain a subset
of differentially expressed genes in iPS vs ES cell com-
parison, it is more difficult to discern the mechanism
behind the highly significant overlap between genes
upregulated in iPS vs ES cells a n dt h o s eu p r e g u l a t e di n
Table 2 Functional annotation clustering of 199 DAVID IDs that were upregulated in hiPS-BCs vs hES-BCs
GO term Category No. of
genes
p- value Genes
ECM-receptor
interactions
KEGG
pathway
12 2.7E-9 CD47, CD36, COL4A1, CD44, COL6A3, COL3A1, COL1A2, RELN, COL1A1, LAMB1, COL5A2,
COL5A1
Collagen Cellular
component
9 4.5E-9 COL4A1, LUM, COL6A3, COL3A1, COL1A2, COL12A1, COL1A1, COL5A2, COL5A1
Fibrillar
collagen
Cellular
component
6 1.4E-7 LUM, COL3A1, COL1A2, COL1A1, COL5A2, COL5A1
Tissue
development
Biological
process
20 3.3E-4 EDN3, CAV1, PPHLN1, COL3A1, ANXA1, KITLG, POSTN, SNAI2, COL5A2, COL5A1, CD44, HOXA5,
CTGF, HOXB5, HLX, PRKAR1A, COL1A2, COL1A1, NR2F2, PITX1
Skin
development
Biological
process
5 3.6E-4 COL3A1, COL1A2, COL1A1, COL5A2, COL5A1
Focal adhesion KEGG
pathway
10 5.7E-4 CAV1, COL4A1, COL6A3, COL3A1, COL1A2, RELN, COL1A1, LAMB1, COL5A2, COL5A1
GO-terms that were significantly overrepresented (enrichment score > 3, p < 0.001,) and genes included in each category are shown. The GO-terms shown in this
table all belong to the same annotation cluster with the enrichment score of 4.56.
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Page 11 of 19Figure 6 Expression of cardiac- and ES cell-specific transcripts. A. Comparison of expression levels of 42 known cardiac transcripts in iPS-BCs
and ES-BCs. Data are presented as mean gene expression of triplicate samples in relative intensity units. Expression levels of all transcripts were
not statistically significant between iPS-BCs and ES-BCs (p > 0,05). For genes, such as HAND1, MYL3 or TBX2, the mean intensity values strongly
differ, but the difference is not statistically significant because of high variability in triplicate samples. B. Heat map presentation of expression
levels of 27 ES cell-specific genes. Among all genes, only the expression of CYP26A1, NANOG and ABHD9 was statistically different between
undifferentiated and differentiated iPS and ES cells. Data for additional CM- and ES cell-specific genes are given in the Additional file 6, Tables
S12-S14.
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Figure 7 Gene ontology and KEGG pathway analysis of genes upregulated in beating clusters of ES and iPS cells. Processes and
pathways found to be most overrepresented in microdissected human iPS-BCs and ES-BCs are presented for categories: biological processes (A),
molecular function (B), cellular pathway (C) and KEGG pathways (D). Detailed lists of GOterms significantly enriched in iPS-BCs and ES-BCs and
the corresponding statistical information are given in Table S20. The p-values under Venn diagrams have been calculated using the Fisher’s exact
test (we used 17593 as the total number of GO-terms in the GO-database in these calculations).
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Page 13 of 19iPS-BC vs ES-BCs. It is unlikely that differential expres-
sion of these genes resulted from differential amounts of
contaminating murine feeder cells in BCs derived from
two types of stem cells, because iPS and ES cells were
maintained and differentiated under the same conditions
for all three respective biological replicates. Differential
contamination of BCs with pluripotent stem cells is also
unlikely, because qRT-PCR analyses demonstrated that
the expression of endogenous OCT4 decreased to a
similar extent upon differentiation of both ES and iPS
cells, and SOX2 could not even be detected in both
types of BCs. We have also excluded the possibility that
some of the common iPS cell- and iPS-BC-enriched
genes are upregulated as a consequence of ectopic reac-
tivation of lentiviral OCT4 gene in iPS-BCs, because
these genes had not been reported to be the Oct4 tar-
gets in previous studies [41-43]. Instead, our analyses
indicate that transcriptional differences between iPS-BCs
and ES-BCs may, at least partially, be caused by differ-
ential cellular composition in these clusters. As revealed
by gene ontology analysis, biological terms related to
collagen, extracellular matrix, cell adhesion and tissue
development were enriched in iPS-BCs compared to ES-
BCs by about 3-fold. It remains to be determined
whether higher content of fibroblasts in iPS-BCs (or
other cell types expressing the overrepresented tran-
scripts) is due to specific properties of the iPS cell line
used in this study or due to inherently better capability
of different iPS cell lines to differentiate towards cells of
their somatic origin. Just recently, two studies using
murine iPS cell lines derived from different somatic cell
types demonstrated that iPS cells retain some DNA
methylation signature characteristic of their somatic tis-
sue of origin and that their cellular origin influences the
in vitro differentiation propensity of iPS cells [44,45].
The disadvantage of using microdissected beating
clusters in our study, which contain CMs and multiple
other cell types, is that we are not able to provide a defi-
nitive answer to the question whether epigenetic mem-
ory of somatic cells may still be retained in some
mature iPS cell derivatives. To answer this question,
transcriptional profiles of undifferentiated iPS cells and
highly purified differentiated cells derived from several
iPS cell lines should be compared. We have compared
transcriptional profiles of highly purified cardiomyocytes
generated by drug selection from a transgenic murine
iPS and ES cell line, but could not find any evidence for
retention of somatic cell signature in murine iPS-CMs
(Fatima A., manuscript in preparation). The same obser-
vation has been also recently reported for murine car-
diac Nkx2.5-positive progenitor cells isolated by drug
selection from several murine iPS and ES cell lines [46].
In this study, the variability in gene expression profiles
that was seen between undifferentiated iPS and ES cell
lines was even reduced in highly purified lineage-specific
cardiac progenitors. Thus, it is unlikely that CMs pre-
sent in iPS-BCs express any of upregulated genes listed
in our Table 1. However, we can not exclude the possi-
bility that other cell types in iPS-BCs still ectopically
express some of the genes in this list as a consequence
of retention of epigenetic memory of somatic cells.
Clearly, additional studies with different cell lines and
purified differentiated cell populations will be required
to discern between these various possibilities.
A significant progress made in the generation of
genetically intact iPS cells [47,48] renders the investiga-
tion of consequences of transgene reactivation on the
physiology of differentiated cells less relevant. The iPS
cell line used in our present report contain sequences of
reprogramming transgenes stably integrated into their
genome [6] and this may have caused some of the dif-
ferences in gene expression profiles detected between ES
and iPS cells. This notion is supported by observation
that iPS cells generated by non-integrating reprogram-
ming methods are transcriptionally more similar to ES
cells than those generated with stably integrating viral
vectors [40]. Therefore, genetically intact iPS cell lines
should be utilized in future studies. However, it is worth
mentioning that the genetic integration of viral
sequences and incomplete silencing of the lentiviral
OCT4 transgene in iPS-BCs as observed in our study,
and corroborated by Zhang and coworkers [22], appar-
ently did not adversely affect the functional as well as
molecular properties of iPS-CMs. This is in agreement
with the observation that ectopic Oct4 expression in the
heart of adult mice did not lead to any detectable altera-
tions of cell phenotype [49]. Similarly, 303 transcripts
differentially expressed between iPS-BC and ES-BCs did
not appear to exert a measurable affect on functional
properties of CMs contained in iPS-BCs in vitro.
Conclusions
Transcriptional profiles of undifferentiated iPS and ES
cells have been extensively analyzed in the past. In this
study we provide molecular evidence that not only
undifferentiated iPS and ES cells but also their differen-
tiated derivatives contained in spontaneously beating
areas have highly similar global transcriptional profiles.
Minor differences in gene expression that were identi-
fied between iPS and ES cells in undifferentiated and
differentiated state did not appear to significantly affect
the structural or functional properties of iPS cell-derived
cardiomyocytes. However, iPS-BCs appear to retain
some of the iPS cell genetic signature partially due to
enrichment of specific cell types (such as those expres-
sing collagen and ECM-components) and thus may not
be perfectly identical to ES-BCs. These findings empha-
size the necessity for detailed functional and molecular
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Page 14 of 19analyses of mature iPS cell-derivatives so as to deter-
mine the consequences of their expression for the phy-
siology and safety of iPS cell-derivatives.
Methods
Culture of undifferentiated human ES and iPS cells
The human iPS cell line derived from foreskin fibro-
blasts, clone 1 (C1), was kindly provided by James
Thomson (University of Wisconsin, Madison, WI, USA)
[6]. The informed consent of the patient donating the
tissue probe for iPS cell generation was obtained by the
original group (see the reference 6). For comparison we
used the human ES cell line HES-2 that was generated
by the ES Cell International (Singapore, http://www.
escellinternational.com/about_esi/index.html) and
obtained from the repository at the WiCell Research
Institute (Madison, WI, USA, http://www.wicell.org/).
The iPS and ES cells were maintained on irradiated
murine embryonic fibroblasts (MEFs) in DMEM/F12
medium supplemented with Glutamax, 20% knockout
serum replacer, 1% nonessential amino acids (NAA), 0.1
mmol/L b-mercaptoethanol (bME) (Invitrogen, Carls-
bad, CA, http://www.invitrogen.com) and with 4 or 100
ng/ml basic fibroblast growth factor (Peprotech, Rocky
Hill, NJ, USA, http://www.peprotech.com) for ES cells
or iPS cells, respectively. Culture media were changed
daily and the cells were passaged by manual dissection
of cell clusters every 5-6 days. Work with human ES
cells has been approved by the regulatory authorities at
the Robert Koch Institute, Berlin, Germany (permission
number 1710-79-1-4-2-A10).
Cardiac differentiation
Cardiac differentiation of human iPS and ES cells was
carried out on the murine visceral endoderm-like cell
line END2 [15,50]. END2 cell cultures were mitotically
inactivated for 3 hours with 10 μg/ml mitomycin C
(Sigma-Aldrich) and 1.2 × 10
6 cells were plated on 60
mm tissue culture dishes one day before starting the co-
culture. To initiate co-cultures, iPS and ES cell colonies
were dissociated into clumps by either using collagenase
IV (1 mg/ml in DMEM/F-12 at 37°C for 5-10 minutes)
or by manual cutting. The differentiation was carried
out in Knockout-DMEM having 1 mM Lglutamine, 1%
NAA, 0.1 mmol/L (bME) and Penicillin/Streptomycin
(100 U/ml and 100 μg/ml, respectively) devoid of serum
and serum replacement (all reagents were from Invitro-
gen). Medium change was performed at day 5, 9, 12 and
15 after initiating the co-cultures.
RT-PCR and quantitative RT-PCR
Total RNA was isolated using TRIzol Reagent (Invitro-
gen) from iPS or ES cells and from 40-60 iPS cell-
derived BCs (iPS-BCs) or ES cell-derived BCs (ES-BCs)
microdissected at day 18 of differentiation. DNase I-
treated total RNA (500 ng) was reverse-transcribed
using Superscript II RTase (Invitrogen) and random
hexamers. cDNA was diluted 1:4 with sterile tri-destilled
water and 5 μl were amplified using JumpStart™RedTaq
ReadyMix™PCR Reaction Mix (Sigma). Negative controls
were generated in RT reactions in which all reaction
components were included except RTase. Reactions
were terminated at the exponential phase of amplifica-
tion and products were analyzed by agarose gel electro-
phoresis. For quantitative RT-PCR the cDNA probes
were diluted 1:40 and 2 μlw a sa m p l i f i e du s i n gS Y B R
Green PCR Master Mix (Qiagen, Hilden, Germany,
http://www.qiagen.com) in triplicate for each sample
and each gene. Real-time PCRs were performed in a
7500 Fast System Real Time Cycler (Applied Biosystems,
Foster City, CA, USA, http://www.appliedbiosystems.
com) and analyzed with SDSShell 1.4 software (Applied
Biosystems). GAPDH was used for normalization of
expression levels of individual genes. Primers used are
listed in Additional file 1, Table S1. Microarray results
obtained for undifferentiated iPS and ES cells were vali-
dated using Human Embryonic Stem Cell 96 StellAR-
ray™ qPCR array (Lonza, Cologne, Germany, http://
www.lonza.com) (see Supplementary methods in Addi-
tional file 1).
Immuncytochemistry
iPS-BCs and ES-BCs were microdissected on day 15 of
differentiation and plated on fibronectin-coated (2 μg/
ml) μ-dishes
35 mm, low (Ibidi GmbH, Munich, Germany,
http://www.ibidi.de). Three to five days after plating, the
cells were fixed with ice-cold methanol at -20°C. After
washing with phosphate buffered saline (PBS, pH 7.4),
the cells were blocked for one hour with 5% bovine
serum albumin (BSA) in PBS.
Incubation with anti-sarcomeric actinin (Sigma-
Aldrich, clone EA-53, 1:400 dilution) and anti-cardiac
troponin T (cTnT) (Neomarkers, Fremont, CA, clone
13-11, 1:100 dilution) was performed in 1% BSA over-
night at 4°C. After washing with PBS the samples were
incubated with secondary AlexaFluor555-conjugated
antibodies (Invitrogen) for 90 minutes at ambient tem-
perature. Nuclei were counterstained with Hoechst
33432 (2 μg/ml). Samples were embedded in ProLong
Gold antifade reagent (Invitrogen) and observed on
Axiovert Microscope (Carl-Zeiss, Jena, Germany, http://
www.zeiss.de) equipped with the image processing soft-
ware Axiovision 4.5.
Multi-Electrode Array (MEA) measurements
To characterize the functional properties of iPS-CMs
and ES-CMs, extracellular recordings of field potentials
(FPs) were performed using a microelectrode array
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Reutlingen, Germany, http://www.multichannelsystems.
com) as described previously [17,51]. For this purpose,
iPS- and ES-BCs were microdissected on day 15 of dif-
ferentiation, plated on fibronectin-coated (2 μg/ml)
MEA culture plates in DMEM supplemented with 20%
fetal bovine serum (FBS), 1% NAA and 0.1 mmol/L
bME and measured 24-48 hours after attachment. Stan-
dard measurements were performed at 5 kHz in serum-
free IMDM. Isoproterenol (Sigma-Aldrich), a standard
stimulator of the b-adrenergic signaling cascade, and
carbachol (Sigma-Aldrich), a synthetic acetylcholine ana-
logon, were dissolved in serum-free medium. During
recordings, the temperature was kept at 37°C. Data were
analyzed off-line with MATLAB (The Mathworks,
Natick, MA, USA, http://www.mathworks.com) [52].
Measurement of intracellular Ca
2+
Ca
2+ imaging experiments were performed as described
previously [53]. Briefly, BCs were isolated on day 18 of
differentiation and loaded with 2.5 μMF u r a - 2A M
(Molecular Probes, Eugene, OR, USA, http://www.mole-
cularprobes.com) and 0.02% Pluronic-127 (Sigma-
Aldrich) in modified Tyrode solution containing (in
mmol/l): NaCl 140, KCl 5.4, MgCl2 1, sodium pyruvate
2, CaCl2 2, HEPES 10, glucose 10 (pH 7.4) for 30 min-
utes at room temperature [54]. Following the loading
procedure the BCs were washed and incubated for
30 minutes at 37°C for deesterification before measure-
ments. After alternating monochromatic excitation with
340 nm and 380 nm, emitted light was detected using a
charge-coupled device cooled camera (TILL IMAGO
CCD, TILL Photonics, Planegg, Germany, http://www.
till-photonics.com) with a sampling rate of 40 Hz. The
cell aggregates were perfused with Tyrode solution at
1 ml/min. Two perfusion systems were used: chamber
perfusion with approx. 1 cm distance to the clusters and
‘puff’-perfusion placed directly in front of the cells. The
latter was used for caffeine (10 mmol/L) application in
order to estimate the sarcoplasmic reticulum (SR) Ca
2+
load. Ratio F340/F380 data were background subtracted
(TILLvisION, TILL Photonics) and transient parameters
were analyzed with Chart software v5 (ADInstruments,
Castle Hill, Australia, http://www.adinstruments.com).
Results are expressed as mean ± SEM. Statistical analysis
was performed by Student’st - t e s to rp a i r e dt - t e s t
(p-value < 0.05 was considered significant).
Microarray procedure and analysis
Total RNA was extracted from undifferentiated ES and
iPS cells and their corresponding BCs microdissected at
d a y1 8o fd i f f e r e n t i a t i o nu s i n gt h eT R I z o lr e a g e n t .
Human RNA from fetal (FH) and adult hearts (AH) was
purchased from Clontech (Saint-Germain-en-Laye,
France, http://www.clontech-europe.com/). The charac-
teristics of these samples are summarized in Additional
file 1, Table S5. Biotinlabeled cRNA preparation for the
Illumina platform was performed using the Ambion®
Illumina RNA amplification kit (Ambion Europe, Hun-
tington, Cambridgeshire, UK). Afterwards, biotin-labeled
cRNA (750 ng) was hybridized to Sentrix® whole gen-
ome bead chips comprising 48803 probe sets (Human
H T - 1 2 _ V 3 ,I l l u m i n a ,S a nD i e g o ,C A ,U S A ,h t t p : / / w w w .
illumina.com/) and scanned on the Illumina® BeadSta-
tion 500×. Across all samples, 16837 ± 1311 probe sets
(34.5 ± 2.7%) received present calls as defined by the
detection p-value of < 0.05 (n = 3). Raw data extraction
of mRNA microarrays was performed with Beadstudio
3.1.1.0 software using the Beadstudio Gene Expression
Analysis Module 3.1.8. All further analysis was per-
formed in R (http://www.r-project.org, version 2.8.0)
using Bioconductor packages. For further analysis we
used quantile normalization implemented in the affy
package. Variable genes were defined by a coefficient of
variation (SD/mean) between 0.5-10. Determination of
present calls was based on the detection p-value
assessed by Beadstudio software; a gene was called pre-
sent if the detection p-value was < 0.05. Otherwise the
mRNA transcript was called absent. Differentially
expressed genes were selected using a fold change/p-
value filter with the following criteria: only p-values
smaller than 0.05 and an expression change higher than
2 fold and a difference between mean intensity signals
greater than 100 were considered statistically significant
for further analysis. The Benjamini-Hochberg method
w a su s e dt oa d j u s tt h er a wp - v a l u e st oc o n t r o lt h ef a l s e
discovery rate. The fold-change was calculated by divid-
ing the mean intensity of the genes in one group by that
in the other group. If this number was less than one, the
negative reciprocal was used. Hierarchical cluster analy-
sis was performed using the hcluster method in R.
Before clustering, the data were log2 transformed. Dis-
tances of the samples were calculated using Pearson cor-
relation and clusters were formed by taking the average
of each cluster. Principal component (PC) analysis was
performed using the pcurve package in R. When visua-
lizing PC analysis results, the first 3 principal compo-
nents (coordinates) were z-transformed (mean = 0,
standard deviation = 1) and subsequently plotted in 3 D.
The first PC axis accounted for 63.8% of the variance in
the data set of variable transcripts, while the second and
third PC axes accounted for 20.9% and 0.07% of the var-
iance, respectively All heat maps were visualized using
MAYDAY [55]. The enrichment of specific biological
processes, molecular functions, cellular components and
pathways among differentially expressed genes was ana-
lyzed using the Database for Annotation, Visualization
and Integrated Discovery (DAVID, http://david.abcc.
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Page 16 of 19ncifcrf.gov/) bioinformatics resource [56,57] and func-
tional categories and biological pathways annotated by
the Gene ontology tool [58] and the Kyoto Encyclopedia
of Genes and Genomes (KEGG) pathway database [59].
Annotations were considered significantly overrepre-
sented when the p-value of the Fisher’s exact test as
used by DAVID was < 0.001 (enrichment score in func-
tional annotation clustering > 3). Fisher’s exact test was
performed using an online calculator at http://www.
langsrud.com/fisher.htm.
Additional material
Additional file 1: Collection of Figures S1-S3, Tables S1-S5,
Supplemental results, methods and references. This file is a PDF file
containing Figure S1 (characterization of pluripotency markers in
undifferentiated human iPS and ES cells), Figure S2 (assessment of the
cardiogenic potential of human iPS and ES cells), Figure S3 (expression of
pluripotency genes in beating clusters derived from human iPS and ES
cells), Table S1 (primers used for RT-PCR analyses), Table S2 (statistical
analysis of MEA measurements), Table S3 (detailed analysis of
spontaneous Ca2+ transients), Table S4 (coupling between contractions
and Ca2+ transients), Table S5 (description of samples used for
transcriptional profiling), and Supplementary results, methods and
references.
Additional file 2: List of genes that are differentially expressed
across all samples. This file is an Excel file containing Table S6 with the
list of 4254 variable genes and their expression levels in all samples.
Variable genes were defined by a coefficient of variation (SD/mean)
between 0.5-10.
Additional file 3: List of genes differentially expressed between
undifferentiated iPS and ES cells. This Excel file contains Tables S7 and
S8 with the list of genes that are, respectively, upregulated and
downregulated in undifferentiated iPS cells compared to ES cells.
Additional file 4: List of genes differentially expressed between iPS
cell- and ES cell-derived beating clusters (BCs). This Excel file contains
Tables S9 and S10 with the list of genes that are, respectively,
upregulated and downregulated in iPS-BCs compared to ES-BCs.
Additional file 5: Expression levels of selected genes included in
GO-terms that were found to be overrepresented in iPS-BCs
compared to ES-BCs. This PDF file contains the Table S11 displaying the
expression levels of selected fibroblastassociated genes found to be
overexpressed in iPS-BCs compared to ES-BCs.
Additional file 6: Expression levels of selected human ES cell- and
cardiacspecific or enriched genes across all samples. This is a PDF file
in a landscape format containing Table S12 (list of 27 ES cell-specific
genes and their expression levels across all samples), Table S13 (list of 49
human ES cell-enriched genes with their expression levels in all samples)
and Table S14 (list of 83 cardiac specific or enriched genes and their
expression levels across all samples).
Additional file 7: qRT-PCR validation of microarray data with
Human ES cell StellArray qPCR Array (Lonza). This file is a PDF
document containing Table S15 showing the results of qRT-PCR analysis
of expression of selected pluripotency and differentiations genes in
undifferentiated human ES and iPS cells in comparison with microarray
data obtained in this study.
Additional file 8: List of differentially expressed genes in iPS-BC
versus iPS cell comparison and ES-BC versus ES cell comparison.
This file is an Excel file containing Table S16 (list of 1235 genes
upregulated in iPS-BC compared to iPS cells), Table S17 (list of 1014
genes downregulated in iPS-BC compared to iPS cells), Table S18 (list of
875 genes upregulated in ES-BC compared to ES cells), and Table S19
(list of 1103 genes downregulated in ES-BC compared to ES cells).
Additional file 9: Gene ontology analysis of genes upregulated in
iPS-BCs and ES-BCs as compared to their respective
undifferentiated counterparts. This file is a PDF document containing
Table S20 with the list of all overrepresented GO terms in iPS-BCs
compared to iPS cells and in ES-BCs compared to ES cells.
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